These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1787550)

  • 41. Two cases of clonidine abuse/dependence in methadone-maintained patients.
    Lauzon P
    J Subst Abuse Treat; 1992; 9(2):125-7. PubMed ID: 1512800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: a randomised clinical trial.
    Favrat B; Zimmermann G; Zullino D; Krenz S; Dorogy F; Muller J; Zwahlen A; Broers B; Besson J
    Drug Alcohol Depend; 2006 Feb; 81(2):109-16. PubMed ID: 16024184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A nonopioid procedure for outpatient opioid detoxification.
    Ockert DM; Volpicelli JR; Baier AR; Coons EE; Fingesten A
    J Addict Med; 2011 Jun; 5(2):110-4. PubMed ID: 21769056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methadone combined with clonidine versus clonidine alone in opiate detoxification.
    Wilson RS; DiGeorge WS
    J Subst Abuse Treat; 1993; 10(6):529-35. PubMed ID: 8308937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unexpected delirium during Rapid Opioid Detoxification (ROD).
    Golden SA; Sakhrani DL
    J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ambulatory opiate detoxification and primary care: a role for the primary care physician.
    O'Connor PG; Waugh ME; Schottenfeld RS; Diakogiannis IA; Rounsaville BJ
    J Gen Intern Med; 1992; 7(5):532-4. PubMed ID: 1403211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.
    Charney DS; Riordan CE; Kleber HD; Murburg M; Braverman P; Sternberg DE; Heninger GR; Redmond DE
    Arch Gen Psychiatry; 1982 Nov; 39(11):1327-32. PubMed ID: 7138234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonidine for opiate detoxification: outpatient clinical trials.
    Washton AM; Resnick RB
    Am J Psychiatry; 1980 Sep; 137(9):1121-2. PubMed ID: 7425173
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.
    Sullivan M; Bisaga A; Pavlicova M; Choi CJ; Mishlen K; Carpenter KM; Levin FR; Dakwar E; Mariani JJ; Nunes EV
    Am J Psychiatry; 2017 May; 174(5):459-467. PubMed ID: 28068780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Detoxification in withdrawal state in methadone maintenance patients].
    Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
    Foster J; Brewer C; Steele T
    Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrashort noninvasive opiate detoxification.
    Loimer N; Hofmann P; Chaudhry H
    Am J Psychiatry; 1993 May; 150(5):839. PubMed ID: 8480840
    [No Abstract]   [Full Text] [Related]  

  • 56. Clonidine versus long- and short-term methadone-aided withdrawal from opiates. An uncontrolled comparison.
    Kasvikis Y; Bradley B; Gossop M; Griffiths P; Marks I
    Int J Addict; 1990 Oct; 25(10):1169-78. PubMed ID: 2090621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outpatient non-opioid detoxification for opioid withdrawal. Who is likely to benefit?
    McCann MJ; Miotto K; Rawson RA; Huber A; Shoptaw S; Ling W
    Am J Addict; 1997; 6(3):218-23. PubMed ID: 9256987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.
    McGregor C; Ali R; White JM; Thomas P; Gowing L
    Drug Alcohol Depend; 2002 Sep; 68(1):5-14. PubMed ID: 12167548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study.
    Threlkeld M; Parran TV; Adelman CA; Grey SF; Yu J
    Am J Addict; 2006; 15(2):186-91. PubMed ID: 16595358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity.
    Ali R; Thomas P; White J; McGregor C; Danz C; Gowing L; Stegink A; Athanasos P
    Drug Alcohol Rev; 2003 Dec; 22(4):425-31. PubMed ID: 14660132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.